1. Home
  2. KYMR vs IDCC Comparison

KYMR vs IDCC Comparison

Compare KYMR & IDCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$80.14

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo InterDigital Inc.

IDCC

InterDigital Inc.

HOLD

Current Price

$263.51

Market Cap

6.7B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
KYMR
IDCC
Founded
2015
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.7B
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
KYMR
IDCC
Price
$80.14
$263.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
26
2
Target Price
$107.72
$412.50
AVG Volume (30 Days)
451.5K
340.9K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
0.79%
EPS Growth
N/A
N/A
EPS
N/A
2.14
Revenue
$39,211,000.00
$307,404,000.00
Revenue This Year
$10.61
N/A
Revenue Next Year
$8.17
$3.38
P/E Ratio
N/A
$121.91
Revenue Growth
N/A
N/A
52 Week Low
$28.33
$210.88
52 Week High
$103.00
$412.60

Technical Indicators

Market Signals
Indicator
KYMR
IDCC
Relative Strength Index (RSI) 43.79 30.49
Support Level $77.71 $255.86
Resistance Level $89.80 $276.88
Average True Range (ATR) 3.13 9.30
MACD -0.47 0.20
Stochastic Oscillator 25.50 22.72

Price Performance

Historical Comparison
KYMR
IDCC

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

About IDCC InterDigital Inc.

InterDigital Inc is a research and development company focused on wireless, Video, Artificial Intelligence, and related Technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically, it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, with the majority is from China.

Share on Social Networks: